ArticleJournal of medicinal chemistry2020

Discovery of CJ-2360 as a Potent and Orally Active Inhibitor of Anaplastic Lymphoma Kinase Capable of Achieving Complete Tumor Regression.

Jianyong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.